Patient and tumor characteristics
| Characteristics | Median (range), n (%) |
| All cases, n | 10 |
| Age, year | 63.5 (46–74) |
| BMI (kg/m2) | 30.0 (21.5–40.1) |
| Platinum-free interval (months) | 24 (17–145) |
| Pre-operative CA125 (U/mL) | 43 (7–1292) |
| Cytoreduction status | |
| Secondary | 8 (80%) |
| Tertiary | 2 (20%) |
| FIGO stage at diagnosis | |
| IIC | 1 (10%) |
| IIIB | 2 (20%) |
| IIIC | 6 (60%) |
| IV | 1 (10%) |
| Histopathologic subtype | |
| Serous | 8 (80%) |
| Granulosa cell | 1 (10%) |
| Malignant mixed Müllerian tumor (MMMT) | 1 (10%) |
| Tumor grade | |
| 1 | 1/10 (10%) |
| 2 or 3 | 9/10 (90%) |
| Status of primary debulking | |
| R0 | 9 (90%) |
| R1–2 | 1 (10%) |
| Status post-splenectomy | |
| R0 | 10 (100%) |
| Recurrence post-splenectomy | |
| Yes | 5/10 (50%) |
| No | 5/10 (50%) |
BMI, body mass index; CA125, cancer antigen 125; FIGO, International Federation of Gynecology and Obstetrics; R0, resection for cure or complete remission; R1, resection to microscopic residual tumor; R2, resection to macroscopic residual tumor.